x min read

Integrated Cannabis Company Inc (OTCMKTS:ICNAF) Has Massively Paid Off

Integrated Cannabis Company Inc (OTCMKTS:ICNAF) Has Massively Paid Off
Written by
Jim Bloom
Published on
September 24, 2018
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

The cannabis fire has set off companies operating within the sector. Over the past year, cannabis stocks have reported amazing returns; much higher than those previously given by last year’s star: cryptocurrencies. Cannabis, however, is set apart by the fact that it is backed by solid fundamentals as well as the old classical economics rule of available and high demand and supply – which is currently in a shortfall.As a result of the latter, investors have been sinking their funds into these stocks. Their value proposition is backed by the aforementioned rule, an ever-rising revenue position, and growth an immense growth potential; all postulating supernormal returns both in the near and distant future.Integrated Cannabis Company Inc (OTCMKTS:ICNAF) is one of the players in this industry and is therefore been part of the high rolling cannabis stocks. The stock has nearly doubled in value over the past ten days, rising from $.45 to highs of over $.9 over this period. As at 23rd September, the stock was trading at $.815 as shown in the chart below: ICNAF Daily ChartThe above stock performance has led us to take a closer look at the company as we try to evaluate whether the above performance speaks to the company’s stronger value proposition or is merely a short-term adjustment to the changes in the market conditions underlying the cannabis sector as a whole. We thus came up with the following report.

ICNAF: A Brief Overview

Let us first introduce Integrated Cannabis Company Inc to new readers.Integrated Cannabis Company, Inc was founded back in 2011 and is headquartered in British Columbia, Canada. Over the years, they have built a robust team of dedicated scientists who have devoted their time to researching on and developing novel drugs meant to alleviate different problems: sleep deprivation, libido and pain. Currently, their team is made up of dedicated scientists and product engineers who work on utilizing advanced formulations and systems to ensure delivery of the drugs as well as ensure the health of the firm’s clients.All the above is achieved through their continued role with X-Sprays, the research and development firm founded by Dr Clive Spray, PhD a renowned chemist and plant biologist with over 20 years of experience in the field. Through this firm, ICNAF is able to ensure that their drugs are of high quality and that their sprays meet the requirements set by their current clientele.

Developments Affecting ICNAF

With the above in mind, let us evaluate where the firm currently stands.Since the beginning of this year, the firm has done a lot to ensure they maintain their place in the cannabis map. With the map everchanging and new entrants joining every so often, ICNAF has chosen to use strategic partnerships to boost their distribution network as well as boosting their product line. The latter and former have been pivotal to the firm’s current standing and have ensured that their growth trajectory remains positive as elaborated below.

Signed Distribution Agreement

In a bid to further venture into the US market, ICNAF has signed a distribution agreement with a leading operator of wellness and medical cannabis clinics: Empower Clinics Inc (CNSX:EPW). Through this agreement, ICNAF expects that their current novel products, X-SPRAYS™ will be distributed across the US market, ensuring that their market share and presence is felt in the currently fragmented cannabis market.The team at EPW is expected to cater to the marketing and distribution of the drugs, ensuring that ICNAF can focus on the development of higher quality products rather than on the logistics segment. Furthermore, the agreement will see EPW tap into their already existing client base which constitutes 25,000 patients across 15 locations in three states in addition to the over 120,000 patients included in their database. With EPW also opening their flagship base in Canada, there is a lot of opportunity for their growth, therefore, for the growth of ICNAF both in the short and long run.

The Cannabis-Infused Spray

The long period of research and development finally paid off for ICNAF who finally announced the release of the long-awaited THC-infused spray product. This development is no mean feat for the company and presents them with the ability to venture into new markets, allowing for their growth in revenues and market share.Currently, the product is awaiting licensing and approvals prior to its industrial scale manufacture and consecutive distribution in the different markets. The licensing is, however, expected from the State of Colorado.The firm’s management remained exhilarated about the news with their CEO, John Knapp stating:

“We are pleased to be adding THC products to our proprietary line of sprays and plan to launch via distribution in Colorado beginning in Q4 and shall pursue other legal markets thereafter.”

Source:Throughout this period, their goal has been to ensure that the product is well developed. With this already being achieved, their current goal remains to ensure it is marketed to all stakeholders so as to ensure their goal of higher revenues is finally reached.

Conclusion

All in all, it is clear that ICNAF has done a lot to ensure their long-term revenue goal is reached. With their current strategic relationships aligned with their shareholder value maximization framework, all that remains is to ensure the fruitful execution of this process all the way to higher revenues and a better share price.We will be updating our subscribers as soon as we know more. For the latest updates on ICNAF, sign up below!Disclosure: We have no position in ICNAF and have not been compensated for this article.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.